• 검색 결과가 없습니다.

전이성 췌장 선암 환자에게서 FOLFIRINOX 치료 예측 바이오마커로서의 유전자 변이

N/A
N/A
Protected

Academic year: 2021

Share "전이성 췌장 선암 환자에게서 FOLFIRINOX 치료 예측 바이오마커로서의 유전자 변이"

Copied!
2
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

참조

관련 문서

For my study, this being diagnosed with prostate cancer receiving treatment in patients with complementary and alternative therapies for their experience

(Method) Among 102 patients with metastatic liver carcinoma due to colorectal cancer who were treated at Chosun University Hospital from January 2003 to

Patients with breast cancer; ovarian cancer; renal cell carcinoma; pancreatic neuroendocrine cancer; colorectal cancer; head and neck cancer; non-small cell lung

Median overall survival of 28 multiple myeloma patients treated with Cyclophosphamide-Prednisone combination regimens as a primary therapy was 115 weeks.. Median

In addition, the expression of REDD1 was increased when Huh7 cells were treated with PA, and overexpression of REDD1 affected cell survival and lipid

Product Recovery Capital Costs Product Yield Production Rate Final Concentration. Product

In this study we will survey the changes in DNA repair factors during aging in rat, including mismatch repair (MMR), base excision repair (BER), and double-strand break

This study focuses on the overall survival(OS) and the re-recurrence free survival (RFS) rates for patients according to the Milan criteria status at the time of recurrence as